Effect of intravesical Bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder.
D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000601:surgery / Q000628:therapy*; D002291:Carcinoma, Papillary / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011379:Prognosis; D011897:Random Allocation; D001749:Urinary Bladder Neoplasms / Q000601:surgery / Q000628:therapy*
D001500:BCG Vaccine